Page last updated: 2024-11-03

propranolol and Renal Insufficiency

propranolol has been researched along with Renal Insufficiency in 4 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research Excerpts

ExcerptRelevanceReference
"To investigate the mechanism responsible for the increased bioavailability of propranolol in bilateral ureter-ligated (BUL) rats, the intestinal absorption and hepatic extraction of propranolol and metoprolol were evaluated."1.32Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation. ( Hashimoto, Y; Higashi, T; Ohta, T; Okabe, H, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sersté, T1
Melot, C1
Francoz, C1
Durand, F1
Rautou, PE1
Valla, D1
Moreau, R1
Lebrec, D1
Efe, C1
Purnak, T1
Ozaslan, E1
Wong, F1
Salerno, F1
Okabe, H1
Higashi, T1
Ohta, T1
Hashimoto, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Preoperative Beta Blocker Use on Intraoperative Hemodynamics and Postoperative Renal Function in End-stage Liver Disease Patients Undergoing Liver Transplantation[NCT03633812]477 participants (Anticipated)Observational [Patient Registry]2016-10-28Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for propranolol and Renal Insufficiency

ArticleYear
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Ascites; Contraindications; Female; Follow-Up Studies; Humans; Hy

2010
The deleterious effects of propranolol on patients with cirrhosis.
    Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:1

    Topics: Cardiac Output; Humans; Hyponatremia; Liver Cirrhosis; Propranolol; Renal Insufficiency

2011
Beta-blockers in cirrhosis: friend and foe?
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3

    Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Humans; Liver Cirrhosis; Peritonitis; P

2010
Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Cytochrome P-450 Enzyme System; Disease Models, Animal; Glucok

2004